Drug-labels.com

Lumify: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Over-the-counter (OTC)
Strength:
0.025 %
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Lumify

What is LUMIFY used for?

To relieve redness of the eye due to minor eye irritations such as environmental allergies, dryness, and fatigue for adults.

How does LUMIFY work?

LUMIFY causes the blood vessels in the eye to tighten which lessens the redness of the eye when it is irritated.

What are the ingredients in LUMIFY?

Medicinal ingredient: Brimonidine Tartrate

Non-medicinal ingredients: Benzalkonium Chloride, Boric Acid, Calcium Chloride Dihydrate, Glycerin, Potassium Chloride, Sodium Borate Decahydrate, Sodium Chloride, Water +/- Hydrochloric Acid and Sodium Hydroxide.

LUMIFY comes in the following dosage forms:

Ophthalmic solution, brimonidine tartrate 0.025% w/v

Do not use LUMIFY:

  • If you are allergic to any of the ingredients in the product
  • If you are receiving monoamine oxidase inhibitor therapy ((MAOI) drugs for depression or Parkinson’s disease)
  • In neonates and infants (children under the age of 2 years)

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take LUMIFY. Talk about any health conditions or problems you may have, including if you:

  • are breastfeeding a baby, pregnant or intend to become pregnant

  • are taking other prescription or non-prescription products
  • have a severe cardiovascular disorder; liver or kidney impairment

Other warnings you should know about:

  • For use in the eyes only
  • Not approved for use in children (<18 years of age)

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

How to take LUMIFY:

  • To avoid contamination, do not touch tip of container to any surface. Replace cap after using.
  • Remove contact lenses before use. Wait at least 15 minutes before re-inserting contact lenses after use.
  • Wait at least 5 minutes between use of this product and any other eye product.
  • Stop use and ask a doctor if you experience eye pain, changes in vision, continued redness or irritation of the eye or condition worsens or persists for more than 3 days

Usual dose:

Adults (18 years and over): Instill 1 drop in the affected eye(s) every 6-8 hours. Do not use more than 4 times daily.

Overdose:

If swallowed or you think you have used too much LUMIFY, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you forget to apply your eye drops at your normal time, apply as them as soon as you remember. Then go back to the original schedule as directed by the label. Don’t try to catch up on missed drops by applying more than one dose at a time.

What are possible side effects from using LUMIFY?

These are not all the possible side effects you may feel when taking LUMIFY. If you experience any side effects not listed here, contact your healthcare professional.

  • Common: eye redness, application site pain
  • Uncommon: headache, eye irritation, dry eye, feeling of something in the eye, light sensitivity, hypotension

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (http://www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/index-eng.php) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store at 15° C to 25° C. Discard any unused solution 121 days after opening.

Keep out of reach and sight of children.

If you want more information about LUMIFY:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (http://hc-sc.gc.ca/index-eng.php); the manufacturer’s website www.bausch.ca, or by calling 1-888-459-5000.

LUMIFY® is a trademark of Bausch & Lomb Incorporated or its affiliates.

Last Revised: June 15, 2021

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02517698

Revision date stated in the text: June 15, 2021

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Lumify

Rx or OTC
Over-the-counter (OTC)?
DIN 02517698
Schedule(s) NON-PRESCRIPTION DRUGS
Active ingredient(s) Brimonidine tartrate 0.025 %
Dosage form(s) Solution
Route(s) of administration Ophthalmic
Drug class (WHO ATC)
  1. S Sensory organ drugs
    1. S01 Ophthalmologicals
      1. S01E Antiglaucoma preparations and miotics
        1. S01EA Sympathomimetics in glaucoma therapy
          1. S01EA05 Brimonidine
Company BAUSCH & LOMB INC
Current status Marketed
Current status date July 5, 2022

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.